Q2 2023 Earnings Forecast for Anika Therapeutics, Inc. Issued By Barrington Research (NASDAQ:ANIK)

Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) – Investment analysts at Barrington Research dropped their Q2 2023 earnings per share estimates for Anika Therapeutics in a report released on Wednesday, May 10th. Barrington Research analyst M. Petusky now expects that the biotechnology company will post earnings of ($0.27) per share for the quarter, down from […]

Related Keywords

United States ,America , ,Fisher Asset Management ,Tower Research Capital ,Anika Therapeutics Inc ,Anika Therapeutics Company Profile ,Mutual Of America Capital Management ,Diker Management ,Anika Therapeutics ,Jpmorgan Chase Co ,Barrington Research ,Nasdaq ,Get Rating ,Anika Therapeutic ,America Capital Management ,Asset Management ,Research Capital ,Anika Therapeutics Daily ,Nasdaq Anik ,Anik ,Medical ,03525510 ,Earnings Estimates ,